Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin

NCT00927862 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

2415

Enrollment

OTHER

Sponsor class

Conditions

Thromboembolism

Interventions

GENETIC: IWPC adapted genotype-guided dosing algorithm for warfarin
GENETIC: Modified IWPC genetic-guided warfarin dosing algorithm
OTHER: Standard of care treatment

Sponsor

Intermountain Health Care, Inc.